AU Patent

AU2011201337B2 — Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions

Assigned to Bayer Healthcare LLC · Expires 2013-02-14 · 13y expired

What this patent protects

CNRPonbl\DCC\MDT\3548993-1 DOC-23/03/2011 FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS Abstract A compound of Formula (I): (I) salts thereof, prodrugs thereof, metabolites thereof, s pharmaceutical compositions con…

USPTO Abstract

CNRPonbl\DCC\MDT\3548993-1 DOC-23/03/2011 FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS Abstract A compound of Formula (I): (I) salts thereof, prodrugs thereof, metabolites thereof, s pharmaceutical compositions containing such a compound, and use of such compound and compositions to treat diseases mediated by raf, VEGFR, PDGFR, p38 and flt-3

Drugs covered by this patent

Patent Metadata

Patent number
AU2011201337B2
Jurisdiction
AU
Classification
—
Expires
2013-02-14
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Healthcare LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.